Case report| Volume 23, ISSUE 4, P529-530, August 2009

The Use of Methylene Blue for Vasodilatory Shock in a Pediatric Lung Transplant Patient

Published:February 17, 2009DOI:
      METHYLENE BLUE recently has been advocated to reverse the effects of vasodilatory shock. However, there is not widespread acceptance of its use in unique patient populations. The authors report a case of methylene blue administration in a nonseptic vasoplegic patient belonging to 2 groups in which methylene blue for vasodilatory shock has not been widely studied: pediatric patients and lung transplant patients.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Levin R.L.
        • Degrange M.A.
        • Bruno G.F.
        • et al.
        Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
        Ann Thorac Surg. 2004; 77: 496-499
        • Hammon J.
        Extracorporeal circulation: The response of humoral and cellular elements of blood to extracorporeal circulation.
        in: Cohn L.H. Cardiac Surgery in the Adult. (ed 3). McGraw-Hill, New York, NY2008: 370-389
        • Shanmugam G.
        Vasoplegic syndrome—The role of methylene blue.
        Eur J Cardiothorac Surg. 2005; 28: 705-710
        • Mayer B.
        • Brunner F.
        • Schmidt K.
        Inhibition of nitric oxide synthesis by methylene blue.
        Biochem Pharmacol. 1993; 45: 367-374
        • Kwok E.S.H.
        • Howes D.
        Use of methylene blue in sepsis: A systematic review.
        J Intensive Care Med. 2006; 21: 359-363
        • Memis D.
        • Karamanlioglu B.
        • Yuksel M.
        • et al.
        The influence of methylene blue infusion on cytokine levels during severe sepsis.
        Anaesth Intensive Care. 2002; 30: 755-762
        • Donati A.
        • Conti G.
        • Loggi S.
        • et al.
        Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?.
        Crit Care Med. 2002; 30: 2271-2277
        • Andresen M.
        • Dougnac A.
        • Diaz O.
        • et al.
        Use of methylene blue in patients with refractory septic shock: Impact on hemodynamics and gas exchange.
        J Crit Care. 1998; 13: 164-168
        • Preiser J.C.
        • Lejeune P.
        • Roman A.
        • et al.
        Methylene blue administration in septic shock: A clinical trial.
        Crit Care Med. 1995; 23: 259-264
        • Gachot B.
        • Bedos J.P.
        • Veber B.
        • et al.
        Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.
        Intensive Care Med. 1995; 21: 1027-1031
        • Kirov M.Y.
        • Evgenov O.V.
        • Evgenov N.V.
        • et al.
        Infusion of methylene blue in human septic shock: A pilot, randomized, controlled study.
        Crit Care Med. 2001; 29: 1860-1867
        • Rimar S.
        • Gillis C.N.
        Pulmonary vasodilation by inhaled nitric oxide after endothelial injury.
        J Appl Physiol. 1992; 73: 2179-2183
        • Avontuur J.A.
        • Tutein Nolthenius R.P.
        • van Bodegom J.W.
        • et al.
        Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study.
        Crit Care Med. 1998; 26: 660-667
        • López A.
        • Lorente J.A.
        • Steingrub J.
        • et al.
        Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock.
        Crit Care Med. 2004; 32: 21-30
        • Salaris S.C.
        • Babbs C.F.
        • Voorhees 3rd, W.D.
        Methylene blue as an inhibitor of superoxide generation by xanthine oxidase.
        Biochem Pharmacol. 1991; 42: 499-506